MEDICAID: Provides relative to the Medicaid Pharmaceutical and Therapeutics Committee
Read by title, under the rules, referred to the Committee on Health and Welfare.
Email me when HB 927 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HB 927. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill revises the law governing the Medicaid Pharmaceutical and Therapeutics Committee by adding a new member slot for a physician or pharmacist from each Medicaid managed‑care organization and by deleting an existing provision. It also removes certain restrictions on HIV/AIDS medications. These changes aim to broaden professional input on Medicaid drug decisions and improve access to HIV/AIDS treatments.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HB 927
3 free questions a day, no accountHearings
- Meeting on April 1, 2026 of the House Committee on Health and WelfareMeeting on April 1, 2026 of the House Committee on Health and Welfare · Apr 1, 2026
History
- Read by title, under the rules, referred to the Committee on Health and Welfare.
- Under the rules, provisionally referred to the Committee on Health and Welfare.
Sponsors
- Wayne McMahen (R) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HB 927 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 927 freeOr ask your AI assistant about HB 927 directly:
Add to Claude, ChatGPT or Cursor